Learn what potential challenges come with mHealth apps and how to overcome them to best fit patient needs.
Does a lack of abortion access fuel mental illness by exacerbating stress, poverty, and domestic violence? Learn more here.
Psychiatrists have valuable insights on political and societal issues that can be shared with the psychiatric community.
How can we improve rural mental health?
In this CME, learn more about the pathophysiology of HIV-associated neurocognitive disorder and to review the research and various tools used to aid in the diagnosis.
Drs Paul Doghramji and Leslie Citrome share approaches to communicate with patients and increase awareness of insomnia disorder
These 3 stories offer a lesson in humility to psychiatry.
In the early 20th century, British and American doctors looked for the causes of mental illnesses elsewhere in the body, with gruesome results.
We seek to reduce vaccine side effects—but what about the social media-compounded fears of anti-COVID vaccination?
Dance/movement therapy has proven to be effective in treating children with trauma, making dance something that can change the way a child develops psychologically.
An understanding of evolving risk factors and pathophysiology is vital to optimal clinical management of anxiety disorders and PTSD.
Judith S. Beck, PhD, and Janeé M. Steele, PhD, engage in a conversation about how clinicians from all backgrounds can address issues of race in session and also empower Black patients with a sense of personal pride in their identities.
“The acute and long-term psychological consequences of this tragedy will require large-scale aid.”
Research is underway to make psychedelics agents a treatment option for psychiatric disorders.
This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.
“We didn’t pick this political fight, but we will stand up for our patients, for the policies of this House, and for our profession.”
The vaccine needs to be appropriately framed: as a benefit, not a risk.
Has the media’s obsession with the COVID-19 pandemic put global mental health at risk?
One professional psychiatrist shares his account of living with bipolar affective disorder.
This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.
D-cycloserine may help patients with anxiety disorders, or it might make their anxiety worse. Find out how to use it safely.
"Our findings provide a mechanistic explanation for the well-known variations in individual responses to drugs and suggest that subjective beliefs could be a direct target for the treatment of substance use disorders," said Xiaosi Gu, PhD, senior author of the study.
How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?
What is the mindset of “anti-vaxxers,” and how can you connect with them as a clinician?
We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Collecting fees is essential, but it can be uncomfortable and even difficult. What strategies can you use to ease the burden?
Caring for physician-patients can be a challenge…
This moment in history cannot be lost. When you ask us if we are okay, be prepared to hear us say we are not . . . and never have been. Then be prepared to do more.